bml 190 has been researched along with Encephalopathy, Toxic in 1 studies
indomethacin morpholinylamide: an inverse agonist of the cannabinoid CB2 receptor
| Excerpt | Relevance | Reference |
|---|---|---|
| " 2 Delta(9)-and Delta(8)-tetrahydrocannabinol (THC) were toxic when added directly to SH-SY5Y neuroblastoma cells." | 1.32 | Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor. ( Bissonnette, CJ; Klegeris, A; McGeer, PL, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Klegeris, A | 1 |
| Bissonnette, CJ | 1 |
| McGeer, PL | 1 |
1 other study available for bml 190 and Encephalopathy, Toxic
| Article | Year |
|---|---|
Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor.
Topics: Astrocytes; Camphanes; Cannabinoid Receptor Modulators; Cannabinoids; Cell Line; Cytokines; Dronabin | 2003 |